These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4369076)

  • 1. Properties of the abnormal human plasma lipoprotein (LP-X) characteristic of cholestasis after chemical modification with succinic anhydride.
    Jonas A; Seidel D
    Arch Biochem Biophys; 1974 Jul; 163(1):200-10. PubMed ID: 4369076
    [No Abstract]   [Full Text] [Related]  

  • 2. A method for quantitative determination of the abnormal lipoprotein of cholestasis, LP-X.
    Ritland S
    Clin Chim Acta; 1974 Sep; 55(3):359-66. PubMed ID: 4369722
    [No Abstract]   [Full Text] [Related]  

  • 3. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.
    Seidel D; Alaupovic P; Furman RH
    J Clin Invest; 1969 Jul; 48(7):1211-23. PubMed ID: 4978447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the quantitative determination of the abnormal lipoprotein (LP X) of obstructive jaundice.
    Magnani HN; Alaupović P
    Clin Chim Acta; 1972 May; 38(2):405-11. PubMed ID: 4337344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the structure and metabolism of lipoprotein-X (LP-X), the abnormal plasmalipoprotein in cholestasis (author's transl)].
    Seidel D
    Klin Wochenschr; 1977 Jul; 55(13):611-23. PubMed ID: 197298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of lipoprotein X and beta-lipoprotein by zonal centrifugation or hydroxyapatite chromatography.
    Danielsson B; Johansson BG; Petersson BG
    Clin Chim Acta; 1973 Sep; 47(3):365-9. PubMed ID: 4355412
    [No Abstract]   [Full Text] [Related]  

  • 8. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.
    Seidel D; Alaupovic P; Furman RH; McConathy WJ
    J Clin Invest; 1970 Dec; 49(12):2396-407. PubMed ID: 5480863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of human serum low density lipoproteins after modification by succinic anhydride.
    Scanu A; Pollard H; Reader W
    J Lipid Res; 1968 May; 9(3):342-9. PubMed ID: 5650928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins.
    Alaupovic P; Lee DM; McConathy WJ
    Biochim Biophys Acta; 1972 Apr; 260(4):689-707. PubMed ID: 4337564
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms.
    McConathy WJ; Alaupovic P
    FEBS Lett; 1974 Apr; 41(1):174-8. PubMed ID: 4369237
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice.
    Kostner GM; Laggner P; Prexl HJ; Holasek A
    Biochem J; 1976 Aug; 157(2):401-7. PubMed ID: 183749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An abnormal low-density lipoprotein in cholestases. I. Isolation and characterization].
    Seidel D; Alaupovic P
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1774-80. PubMed ID: 4989048
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of maleylated and partially delipidated low density lipoproteins from human plasma.
    Simons K; Helenius A
    Ann Med Exp Biol Fenn; 1969; 47(1):48-51. PubMed ID: 4983181
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence of agar gel electrophoresis changes of lipoprotein-X after phospholipase A and deoxycholic acid.
    Frisón JC; Ras MR; Rubiés-Prat J; Masdeu S; Schwartz S
    Digestion; 1977; 16(1-2):199-202. PubMed ID: 210069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cholestasis lipoprotein (LP-X). Characteristics, diagnostic value and distribution in some liver diseases in children].
    Vierucci A; Monterisi N; Dettori M; Niccoli P; Petriccioli G
    Minerva Pediatr; 1974 Feb; 26(3):131-43. PubMed ID: 4206814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of an abnormal lipoprotein (LP-X) associated with cholestasis].
    Vergani C; Pietrogrande M; Grondona MC; Pizzolato M
    Minerva Med; 1973 Apr; 64(28):1461-85. PubMed ID: 4196357
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved techniques for assessment of plasma lipoprotein patterns. I. Precipitation in gels after electrophoresis with polyanionic compounds.
    Seidel D; Wieland H; Ruppert C
    Clin Chem; 1973 Jul; 19(7):737-9. PubMed ID: 4197247
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of antibodies. I. The effect of the new modifying agent, dodecylsuccinic anhydride, on properties of IgG immunoglobulins.
    Starościk K; Lisowski J
    Eur J Immunol; 1972 Feb; 2(1):62-8. PubMed ID: 4628328
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis.
    Simon JB; Poon RW
    Gastroenterology; 1978 Aug; 75(2):177-80. PubMed ID: 208914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.